Xoma | XOMA - Net Income

Stock Price
26.42
Daily Change
-0.03 -0.11%
Monthly
6.28%
Yearly
21.81%
Q1 Forecast
24.75

Xoma reported $-17.24M in Net Income for its fiscal quarter ending in September of 2024.





Net Income Change Date
AbbVie USD 1.82B 1.63B Dec/2025
Agenus USD -25.27M 20.59M Mar/2025
Agios Pharmaceuticals USD -108.04M 4.61M Dec/2025
Ardelyx USD -969K 18.11M Sep/2025
aTyr Pharma USD -25.74M 6.21M Sep/2025
BioMarin Pharmaceutical USD -46.57M 15.83M Dec/2025
Celldex Therapeutics USD -81.32M 14.27M Dec/2025
Curis USD -11.8M 80K Jun/2024
Eli Lilly USD 6.64B 1.05B Dec/2025
Emergent BioSolutions USD -261.3M 78.3M Jun/2023
Incyte USD 299.28M 124.89M Dec/2025
MacroGenics USD 16.82M 53.07M Sep/2025
Novartis USD 3.93B 96M Sep/2025
Novartis USD 3.93B 113M Sep/2025
Pfizer USD -1.65B 5.19B Dec/2025
Prothena USD -36.54M 89.23M Sep/2025
Regeneron Pharmaceuticals USD 844.6M 615.4M Dec/2025
Xoma USD -17.24M 33.23M Sep/2024